Emerging Therapeutic Strategies for COVID-19 Patients

Authors

Shudong Zhu
Xialing Guo
Kyla Geary
Dianzheng Zhang, Philadelphia College of Osteopathic MedicineFollow

Document Type

Article

Publication Date

3-12-2020

Abstract

Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention.

Publication Title

Discoveries

Volume

8

Issue

1

First Page

105

Last Page

105

PubMed ID

32309622

Comments

This article was published in Discoveries, Volume 8, Issue 1, page e105.

The published version is available at https://dx.doi.org/10.15190%2Fd.2020.2

Copyright © 2020 Zhu et al. and Applied Systems. CC-BY 4.0

Recommended Citation

Zhu, Shudong; Guo, Xialing; Geary, Kyla; and Zhang, Dianzheng, "Emerging Therapeutic Strategies for COVID-19 Patients" (2020). PCOM Scholarly Papers. 2053.
https://digitalcommons.pcom.edu/scholarly_papers/2053